Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Giannoukakis

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Current Diabetes Reports|December 13, 2021
Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes EndotypesAlessandra Petrelli, Anna Giovenzana, Vittoria Insalaco, et al.
Immunologic Research|March 6, 2007
Gene therapy for type 1 diabetes: is it ready for the clinic?Antonella D'Anneo, Pleunie Rood, Rita Bottino, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2015
Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulationCarl Engman, Yi Wen, Wilson S Meng, et al.
Diabetes|December 21, 2013
It's time to bring dendritic cell therapy to type 1 diabetesRémi J Creusot, Nick Giannoukakis, Massimo Trucco, et al.
Metabolism: Clinical and Experimental|August 3, 2024
Longitudinal proteomics of leptin treatment in humans with acute and chronic energy deficiency-induced hypoleptinemia reveal novel, mainly immune-related, pleiotropic effectsKonstantinos Stefanakis, Martina Samiotaki, Vassiliki Papaevangelou, et al.
Immunologic Research|April 9, 2011
Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacityValentina Di Caro, Antonella D'Anneo, Brett Phillips, et al.
Diabetes|December 29, 2005
Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cellsJo Harnaha, Jennifer Machen, Marietta Wright, et al.
Journal of Pharmaceutics & Drug Delivery Research|September 16, 2022
Hydrogel Dressings for Chronic Wound Healing in Diabetes: Beyond HydrationPaul R Hartmeier, Ngoc B Pham, Ketki Y Velankar, et al.
Plos One|September 3, 2010
Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in miceMaliha Zahid, Brett E Phillips, Sean M Albers, et al.
Molecular Pharmaceutics|February 20, 2013
Retaining antibodies in tumors with a self-assembling injectable systemYi Wen, Harold R Kolonich, Kristen M Kruszewski, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Current Diabetes Reports|December 13, 2021
Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes EndotypesAlessandra Petrelli, Anna Giovenzana, Vittoria Insalaco, et al.
Immunologic Research|March 6, 2007
Gene therapy for type 1 diabetes: is it ready for the clinic?Antonella D'Anneo, Pleunie Rood, Rita Bottino, et al.
Clinical Immunology (Orlando, Fla.)|March 17, 2015
Generation of antigen-specific Foxp3+ regulatory T-cells in vivo following administration of diabetes-reversing tolerogenic microspheres does not require provision of antigen in the formulationCarl Engman, Yi Wen, Wilson S Meng, et al.
Diabetes|December 21, 2013
It's time to bring dendritic cell therapy to type 1 diabetesRémi J Creusot, Nick Giannoukakis, Massimo Trucco, et al.
Metabolism: Clinical and Experimental|August 3, 2024
Longitudinal proteomics of leptin treatment in humans with acute and chronic energy deficiency-induced hypoleptinemia reveal novel, mainly immune-related, pleiotropic effectsKonstantinos Stefanakis, Martina Samiotaki, Vassiliki Papaevangelou, et al.
Immunologic Research|April 9, 2011
Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacityValentina Di Caro, Antonella D'Anneo, Brett Phillips, et al.
Diabetes|December 29, 2005
Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cellsJo Harnaha, Jennifer Machen, Marietta Wright, et al.
Journal of Pharmaceutics & Drug Delivery Research|September 16, 2022
Hydrogel Dressings for Chronic Wound Healing in Diabetes: Beyond HydrationPaul R Hartmeier, Ngoc B Pham, Ketki Y Velankar, et al.
Plos One|September 3, 2010
Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in miceMaliha Zahid, Brett E Phillips, Sean M Albers, et al.
Molecular Pharmaceutics|February 20, 2013
Retaining antibodies in tumors with a self-assembling injectable systemYi Wen, Harold R Kolonich, Kristen M Kruszewski, et al.
Pageof 8